What Does an End-of-Life Doula Do for Patients With Cancer?

End-of-life doulas have become an increasingly visible presence alongside hospice and palliative care teams, yet confusion persists about what the role entails, particularly among clinicians who have not worked alongside one directly. Unlike hospice nurses or palliative care physicians, doulas operate outside the medical system entirely, offering a form of support that is emotional, practical, and relational rather than clinical. That distinction has become more relevant as public awareness of the role grows, including recent portrayals in mainstream television.

In an interview with CancerNetwork®, Kim Stravers, an International End of Life Doula Association (INELDA)–certified end-of-life doula based in Phoenix, Arizona, offered a foundational definition of the role for clinicians who may be encountering the concept for the first time. Stravers explained that despite the many different terms used across the field, including death doula and death midwife, the common thread is that doulas serve as non-medical companions to people who are dying and to the people who support them. She detailed the breadth of that support, noting that it extends beyond patients themselves to include family members and others bereaved by sudden or unexpected loss, including death by suicide or accident.

Transcript:

CancerNetwork: What does an end-of-life doula do?

There are many different definitions of what constitutes an end-of-life doula, a death doula, or a death midwife—there are also many names for this kind of work. The one I like to center on, and I think the essence of any definition, is that we are non-medical companions to [people] who are dying and the people who support them. We provide emotional, practical, logistical, and relational support to people as they’re confronting their mortality. We also support people who have survived someone who has died unexpectedly, whether that be through suicide, through accident, or simply a death that becomes more accelerated than anticipated in their disease trajectory.